A TRANSFORMED MONOCYTE CELL LINE, A PHARMACEUTICAL COMPOSITION FOR DIAGNOSING ATHEROSCLEROSIS COMPRISING THE CELL LINE, AND A METHOD OF SCREENING DRUG CANDIDATES FOR TREATING ATHEROSCLEROSIS USING THE CELL LINE

摘要

The present invention provides a mononuclear cell line which transforms monocyte as a recombinant vector comprising a sodium/iodide symporter (NIS) coding gene, a pharmaceutical composition for diagnosing atherosclerosis comprising the mononuclear cell line, a method for obtaining molecular imaging data in order to diagnose atherosclerosis comprising molecular imaging gain using the mononuclear cell line and a method for screening candidate drugs in order to treat atherosclerosis using the mononuclear cell line.